NASDAQ:BLCM Shareholder Alert: Lawsuit Alleges Misleading Statements by Bellicum Pharmaceuticals Inc
An investor, who purchased shares of Bellicum Pharmaceuticals Inc (NASDAQ:BLCM), filed a lawsuit in over alleged Securities Laws violations by Bellicum Pharmaceuticals Inc.
View full press release